Chad Decker Email & Phone Number

San Diego, California, Us

Jupiter, Florida, Us

As the Chief Commercial Officer my responsibilities at TwinStrand™ Biosciences are to develop and execute the commercial strategy for multiple vertical markets. We have identified key and strategic partnerships for licensing agreements for liquid biopsy, and are building out portfolio markets with standard products. We are also committed to developing emerging diagnostics with pharmaceutical partners for targeted drug resistance and genotoxicity. As with any disruptive technology, we continue to develop content to enable aggressive innovation to enhance complimentary technologies while also providing revolutionary opportunities to advance medicine. TwinStrand™ Biosciences was founded in 2016 to commercialize Duplex Sequencing™, a patented biochemistry and software solution that enhances the resolution of existing DNA sequencing systems by over 100,000 fold. Duplex Sequencing™ enables rapid, actionable, rare-variant detection in key markets such as cancer diagnostics, genotoxicity, forensics, and any application where identifying ultra-rare mutations before they proliferate is critical to success. Learn more at www.twinstrandbio.com

Woburn, Ma, Us

Quad Technologies is a cutting edge biotechnology company that is disrupting the cell separation and activation market with an innovative gel technology called QuickGel. QuickGel is being rapidly adopted in the CAR-T space. Quad offers a magnetic bead free alternative that allows for the elimination of a unit of operation in a much more scalable environment to address the evolving needs of commercialized cell and gene therapies. The benefits of this new technology beyond eliminating a debeading step, is the ability to drive more desirable phenotypes, improved transduction efficiency, and decreased dosing steps. My role is to develop the commercialization plan. Now, with a new GMP facility coming on line, we are poised to sign agreements with global go-to-market partners, key cell and gene therapy innovators, as well as addressing a market for custom activation reagents.

Hilden, North Rhine-Westphalia, De

I was overseeing the global Business Development and Marketing teams for the Enzymatic portfolio, Quanta , SGS, as well as other Qiagen owned entities

Waltham, Ma, Us

I oversaw the teams at our key strategic national reference labs. This entails there supply chain management, project pipelines, and developmental partnerships.

Waltham, Ma, Us

Switzerland 🇨🇭 , Ch